PMC:7247521 / 37275-37374 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"622","span":{"begin":53,"end":61},"obj":"Disease"},{"id":"623","span":{"begin":70,"end":91},"obj":"Disease"}],"attributes":[{"id":"A622","pred":"tao:has_database_id","subj":"622","obj":"MESH:C000657245"},{"id":"A623","pred":"tao:has_database_id","subj":"623","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"3.8 Validation of drug positioning for QFPD against COVID-19 via the robustness of disease network"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T567","span":{"begin":19,"end":23},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T568","span":{"begin":53,"end":61},"obj":"SP_7"}],"text":"3.8 Validation of drug positioning for QFPD against COVID-19 via the robustness of disease network"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T68","span":{"begin":53,"end":61},"obj":"Disease"}],"attributes":[{"id":"A68","pred":"mondo_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"3.8 Validation of drug positioning for QFPD against COVID-19 via the robustness of disease network"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T321","span":{"begin":19,"end":23},"obj":"Chemical"}],"attributes":[{"id":"A321","pred":"chebi_id","subj":"T321","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"3.8 Validation of drug positioning for QFPD against COVID-19 via the robustness of disease network"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T275","span":{"begin":0,"end":99},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"3.8 Validation of drug positioning for QFPD against COVID-19 via the robustness of disease network"}